The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

DICP, The Annals of Pharmacotherapy: Vol. 25, No. 5, pp. 546-552.
© 1991 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foran, R.
Right arrow Articles by Wulf, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foran, R.
Right arrow Articles by Wulf, P.

Research Articles

Evaluating the cost impact of intravenous antibiotic dosing frequencies

RM Foran, JL Brett, and PH Wulf

Cost differences between antibiotic dosing frequencies were studied at Robert Wood Johnson University Hospital. Developing a complete cost profile between antibiotic alternatives is difficult because of role separation within the hospital. To present a more complete profile, the study analyzed the incremental costs associated with the hospital pharmacy and nursing staffs regarding various dosing frequencies, including different iv admixture and administration methods. Results showed that administration of an antibiotic dose costs approximately $3.35 based on labor and material costs associated with admixture and administration. An average of 4.6 minutes/dose saves nurses up to 23 minutes for each patient who receives an antibiotic dosed once rather than six times daily over a 24-hour period. Costs of administration and admixture should be considered in comparisons of combination therapy with monotherapy when deciding between two therapeutically equivalent alternatives.


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
T. M. Meidl, T. W. Woller, A. M. Iglar, and D. G. Brierton
Implementation of pharmacy services in a telemedicine intensive care unit
Am. J. Health Syst. Pharm., August 1, 2008; 65(15): 1464 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
A. D. Tice, R. S. Turpin, C. T. Hoey, B. A. Lipsky, J. Wu, and M. A. Abramson
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections
Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1080 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. P. Samsa, D. B. Matchar, J. Harnett, and J. Wilson
A Cost-Minimization Analysis Comparing Azithromycin-Based and Levofloxacin-Based Protocols for the Treatment of Patients Hospitalized With Community-Acquired Pneumonia: Results From the CAP-IN Trial
Chest, November 1, 2005; 128(5): 3246 - 3254.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. A. Paladino, L. D. Gudgel, A. Forrest, and M. S. Niederman
Cost-Effectiveness of IV-to-Oral Switch Therapy: Azithromycin vs Cefuroxime With or Without Erythromycin for the Treatment of Community-Acquired Pneumonia
Chest, October 1, 2002; 122(4): 1271 - 1279.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1991 by Harvey Whitney Books Company.